(Q51530069)

6 April 2018

title

Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors. (English)

1 reference

6 April 2018

0 references

Bartoszyk GD

1

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

6 April 2018

number of pages

15

1 reference

based on heuristic

inferred from page(s)

published in

Life Sciences

1 reference

6 April 2018

volume

62

1 reference

6 April 2018

issue

7

1 reference

6 April 2018

page(s)

649-663

1 reference

6 April 2018

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

1 reference

Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Anxiogenic-like effects induced by stimulation of dopamine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

The role of dopaminergic mechanisms on the brain in various models of anxious states.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Animal models for anxiety and response to serotonergic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Apomorphine response and subtyping of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Clinical effects of apomorphine in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Psychopathological correlates of dopaminergic disturbances in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Aporphines. 34. (-)-2,10,11-Trihydroxy-N-n-propylnoraporphine, a novel dopaminergic aporphine alkaloid with anticonvulsant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Biochemical and functional studies on EMD 49,980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

[3H]SCH 23390 binding to human putamen D-1 dopamine receptors: stereochemical and structure-affinity relationships among 1-phenyl-1H-3-benzazepine derivatives as a guide to D-1 receptor topography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Interaction of [3H]GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

LY 171555-induced hyperdefensiveness in the mouse does not implicate benzodiazepine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Effects of quinpirole on the behaviour shown by mice in the light-dark box and during social interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

B-HT 920 stimulates feeding and antagonizes anorexia induced by ACTH and immobilisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Tourette syndrome, pimozide, and school phobia: the neuroleptic separation anxiety syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Influence of idazoxan on the dopamine D2 receptor agonist-induced behavioural effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Recent advances in the molecular biology of dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Update on dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Characteristics of stably expressed human dopamine D1a and D1b receptors: atypical behavior of the dopamine D1b receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

A functional test identifies dopamine agonists selective for D3 versus D2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

D3 and D2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Differential visualization of dopamine D2 and D3 receptors in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

Mesocorticolimbic dopaminergic systems and emotional states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901160-0

10.1016/S0024-3205(97)01160-0

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

9472724

1 reference

6 April 2018